Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Income Statements (unaudited)

v3.24.1.u1
Condensed Consolidated Income Statements (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 29,722,166 $ 28,300,820
Cost of revenues:    
Total cost of revenues 2,716,076 2,474,685
Selling and marketing expenses 3,886,113 4,160,244
Depreciation and amortization 1,403,906 2,215,055
General and administrative expenses 20,263,692 20,038,476
Total selling, general and administrative expenses 25,553,711 26,413,775
Net loss on disposition or impairment 362,103  
Income (loss) from operations 1,090,276 (653,109)
Other income, net 35,630 3,821,162
Income before income tax expense 1,125,906 3,168,053
Income tax expense 178,927 841,889
Net income $ 946,979 $ 2,326,164
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.06 $ 0.16
Diluted earnings per share (in dollars per share) $ 0.06 $ 0.16
Basic weighted average shares (in shares) 14,801,354 14,566,185
Diluted weighted average shares (in shares) 15,011,286 14,861,734
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 17,537,504 $ 17,127,957
Royalty fees    
Revenues:    
Total revenues 7,587,547 6,866,023
Franchise fees    
Revenues:    
Total revenues 655,873 754,425
Cost of revenues:    
Cost of revenues 2,341,765 2,140,835
Advertising fund revenue    
Revenues:    
Total revenues 2,166,473 1,952,406
Software fees    
Revenues:    
Total revenues 1,386,776 1,210,005
Cost of revenues:    
Cost of revenues 374,311 333,850
Other revenues    
Revenues:    
Total revenues $ 387,993 $ 390,004